Skip to main content
OpenTrials
Completed

NCT Number: NCT01960088

Adolescent Vaccination in Pharmacies

The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Central Pharmacy, Durham, North Carolina, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

NATIONAL SURVEY (probability sample)

Inclusion criteria

  • Being a member of the GfK Knowledge Panel
  • Having a child age 11-18.

Exclusion criteria

● None

PHARMACY DEMONSTRATION PROJECT (convenience sample)

Inclusion criteria

  • Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV vaccine is indicated
  • Child is with the parent

Exclusion criteria

● Being the parent of an adolescent who is immunocompromised, or has other chronic illness, has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine used, or is pregnant or plan to be pregnant within a month of vaccination.

Treatment and study plan

HPV vaccine

Drug

Other names: Gardasil

Primary outcomes

  1. Parents' willingness to get their adolescent children HPV vaccine in pharmacy

    Time frame: At time of study

    Outcome is for the national survey of parents.

  2. Parents' satisfaction with HPV vaccine vaccine administration in the pharmacy

    Time frame: At time of vaccine administration

    Outcome is for demonstration study in a community pharmacy.

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • Merck Sharp & Dohme LLC

Registry information

Official study title

Building Evidence to Expand Adolescent Vaccination in Pharmacies

Acronym: AVIP

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Oct 10, 2013
Registry last updated
Apr 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.